Innovation and opportunity in life sciences

There is an abundance of investment opportunities in the life sciences sector - eight of the 18 new investments bought for the Schroders Capital Global Innovation Trust portfolio since 2019 have been focused on this area. The globally aging population and biomedical innovations, combined with the nature of development-stage businesses is resulting in plentiful potential rewards. Read on to find out more about the milestones being made in this sector.